Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

23 results
Display

Molecular Identification of the Vaccine Strain from the Inactivated Rabies Vaccine

Yang DK, Oh YI, Cho SD, Kang HK, Lee KW, Kim YH, Song JY

Since 1994, several different inactivated rabies vaccines have been used to immunize domestic animals such as dogs, cats, and cattle in South Korea. The Korean Veterinary Authority has conducted safety...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and trial of vaccines against Brucella

Lalsiamthara J, Lee JH

The search for ideal brucellosis vaccines remains active today. Currently, no licensed human or canine anti-brucellosis vaccines are available. In bovines, the most successful vaccine (S19) is only used in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigation on the Frequency and Severity of Common Adverse Reactions of Japanese Encephalitis Vaccines

Kim BY, Kim DH, Lee HJ, Jung SK, Li XS, Go UY, Park SK, Hong YJ

  • KMID: 2278923
  • Korean J Pediatr Infect Dis.
  • 2009 Dec;16(2):183-190.
PURPOSE: To evaluate the number and severity of adverse reactions after Japanese Encephalitis (JE) vaccination in children using different vaccines (inactivated vaccine or live attenuated vaccine) and to determine the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions

Lee JA, Lee NH, Lee JB, Park SY, Song CS, Choi IS, Lee SW

PURPOSE: Porcine reproductive and respiratory syndrome virus (PRRSV) leads to major economic losses in the swine industry. Vaccination is the most effective method to control the disease by PRRSV. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes

Firouzamandi M, Moeini H, Hosseini D, Bejo MH, Omar AR, Mehrbod P, Ideris A

The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Porcine reproductive and respiratory syndrome virus vaccine does not fit in classical vaccinology

Lyoo YS

All vaccines are developed to elicit an effective immune response in vaccinated animals such as innate, humoral and cell mediated response to protect animal health. Quality and intensity of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Principles underlying rational design of live attenuated influenza vaccines

Jang YH, Seong BL

Despite recent innovative advances in molecular virology and the developments of vaccines, influenza virus remains a serious burden for human health. Vaccination has been considered a primary countermeasure for prevention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antibody Response in Cattle and Guinea Pigs Inoculated with Rabies Vaccines

Yang DK, Jeong WH, Kim HH, Nah JJ, Kim JJ, Choi SS, Kim JT, Song JY

One hundred ninety-five rabies cases in cattle were identified in South Korea since 1993. As most of rabies cases have a relation to rabid Korean raccoon dogs (Nyctereutes procyonoides koreensis),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine

Yan F, Zhao Y, Hu Y, Qiu J, Lei W, Ji W, Li X, Wu Q, Shi X, Li Z

The protective efficacy of DNA plasmids encoding avian infectious bronchitis virus (IBV) S1, N, or M protein was investigated in chickens. Chickens were inoculated monovalently (with plasmid pVAX1-16S1, pVAX1-16M, or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine

Choi JG, Lee YJ, Kim JY, Kim YH, Paek MR, Yang DK, Son SW, Kim JH

In order to control the H9N2 subtype low pathogenic avian influenza (LPAI), an inactivated vaccine has been used in Korea since 2007. The Korean veterinary authority permitted the use of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation

Wen F, Ma JH, Yu H, Yang FR, Huang M, Zhou YJ, Li ZJ, Tong GZ

Novel reassortant H3N2 swine influenza viruses (SwIV) with the matrix gene from the 2009 H1N1 pandemic virus have been isolated in many countries as well as during outbreaks in multiple...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neutralizing Antibody Induction and Cytotoxic T Lymphocyte Response to Nakayama-NIH and Beijing-1 as Japanese Encephalitis Virus Vaccine Strains

Cho YJ, Jung SY, Kim YJ, Kim DS, Kim YB, Joo YR, Jung YW, Hur SJ, Nam JH

The Japanese encephalitis virus (JEV), a member of the Flaviviridae family and Flavivirus genus, is transmitted by mosquitoes. JEV, of which some 35,000 cases are recorded every year, is a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens

Shin JH, Mo JS, Kim JN, Mo IP, Ha BD

In Korea, several outbreaks of low pathogenic AI (H9N2) viral infections leading to decreased egg production and increased mortality have been reported on commercial farms since 1996, resulting in severe...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain

Jeon WJ, Lee EK, Lee YJ, Jeong OM, Kim YJ, Kwon JH, Choi KS

Despite the intensive vaccination policy that has been put in place to control Newcastle disease virus (NDV), the recent emergence of NDV genotype VII strains in Korea has led to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents

Yoon SH, Kim HW, Ahn JG, Kim IT, Kim JH, Kong KA, Kim KH

Although the overall incidence of hepatitis A in Korea has been decreasing, adolescents remain highly vulnerable to its outbreaks. This study was conducted to compare the immunogenicity and safety of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country

Song JY, Cheong HJ, Woo HJ, Wie SH, Lee JS, Chung MH, Kim YR, Jung SI, Park KH, Kim TH, Uh ST, Kim WJ

Influenza vaccines are the primary method for controlling influenza and its complications. This study was conducted as a phase 3, randomized, double-blind, controlled, multi-center trial at seven university hospitals to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunization Practices in Children with Renal Disease: A Survey of the Members of Korean Society of Pediatric Nephrology

Park SS, Lee JS, Kim SY

  • KMID: 2322071
  • J Korean Soc Pediatr Nephrol.
  • 2002 Oct;6(2):198-208.
PURPOSE: There is no scientific basis for an immunization policy for children with renal disease who have increased risk of infection in Korea. As an initial step in approaching this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea

Choi JG, Lee YJ, Kim YJ, Lee EK, Jeong OM, Sung HW, Kim JH, Kwon JH

The H9N2 subtype low pathogenic avian influenza is one of the most prevalent avian diseases worldwide, and was first documented in 1996 in Korea. This disease caused serious economic loss...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial

Kang K, Han S, Hong T, Jeon S, Paek J, Kang JH, Yim DS

PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Immunogenicity of a New Trivalent Inactivated Split-virus Influenza Vaccine in Healthy Korean Children: A Randomized, Double-blinded, Active-controlled, Phase III Study

Kang JH, Oh CE, Lee J, Lee SY, Cha SH, Kim DS, Kim HH, Lee JH, Kim JT, Ma SH, Hong YJ, Cheong HJ, Lee HJ

We report results of a randomized, double-blinded, active-controlled, phase III study conducted to evaluate the immunogenicity and safety of a new trivalent inactivated split-virus influenza vaccine (GC501) manufactured by the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr